Free Trial

Leerink Partnrs Boosts Earnings Estimates for Owens & Minor

Owens & Minor logo with Medical background

Owens & Minor, Inc. (NYSE:OMI - Free Report) - Investment analysts at Leerink Partnrs upped their FY2024 earnings per share estimates for shares of Owens & Minor in a research note issued to investors on Monday, February 3rd. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $1.52 per share for the year, up from their previous estimate of $1.48. The consensus estimate for Owens & Minor's current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor's Q4 2024 earnings at $0.53 EPS.

A number of other research firms have also recently weighed in on OMI. Citigroup decreased their price target on Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a report on Tuesday, November 5th. Robert W. Baird decreased their target price on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating for the company in a research note on Tuesday, February 4th. Barclays dropped their price target on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a research note on Tuesday, November 5th. Finally, UBS Group decreased their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $18.50.

View Our Latest Research Report on OMI

Owens & Minor Trading Up 0.0 %

Shares of OMI stock traded up $0.00 during trading hours on Thursday, reaching $8.65. The company had a trading volume of 1,279,932 shares, compared to its average volume of 1,028,394. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor has a twelve month low of $8.43 and a twelve month high of $28.35. The stock's fifty day simple moving average is $13.41 and its 200 day simple moving average is $14.10.

Institutional Trading of Owens & Minor

A number of institutional investors and hedge funds have recently modified their holdings of OMI. FMR LLC grew its position in shares of Owens & Minor by 0.8% during the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company's stock valued at $181,449,000 after buying an additional 90,862 shares during the last quarter. State Street Corp grew its holdings in shares of Owens & Minor by 2.6% during the third quarter. State Street Corp now owns 3,064,547 shares of the company's stock valued at $48,083,000 after purchasing an additional 78,985 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Owens & Minor by 13.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company's stock worth $30,127,000 after purchasing an additional 276,807 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Owens & Minor by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,711,453 shares of the company's stock worth $26,858,000 after purchasing an additional 13,164 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Owens & Minor by 6.0% in the 4th quarter. Bank of New York Mellon Corp now owns 622,921 shares of the company's stock worth $8,142,000 after purchasing an additional 35,105 shares during the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the transaction, the chief financial officer now directly owns 130,822 shares in the company, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 3.59% of the company's stock.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Featured Articles

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines